A. Ceratti

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology.

C. Sempoux, E. Van Cutsem, C. Verslype, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?

C. Sempoux, J. Machiels, J. Canon, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases.

C. Sempoux, J. Machiels, Y. Humblet, 2010, Surgery.

Preoperative gemcitabine-nab-paclitaxel (G-NP) for (borderline) resectable (BLR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC): Feasibility results and early response monitoring by Diffusion-Weighted (DW) MR.

M. Peeters, I. Borbath, L. Annet, 2016 .

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: A phase II study of the Belgian Group of Digestive Oncology.

E. Van Cutsem, C. Verslype, P. Vergauwe, 2011, Journal of Clinical Oncology.

Health data quality improvement by comparing administrative medical data and billing data

Francis H. Roger France, A. Ceratti, C. Beguin, 2008, Int. J. Medical Informatics.